controlled type 2 diabetes /xerostomia.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patient must be literate The patient has been suffering from controlled type 2 diabetes for more than three years The patient has xerostomia Patient in the age range of 18-70 years
Exclusion criteria
Exclusion criteria: History of alcohol consumption History of iodine therapy Suffering from systemic diseases affecting salivary gland function (such as Sjogren's syndrome, rheumatoid arthritis, lupus, etc.) Cardiovascular diseases except hypertension Allergy to aloe vera and ginger Pregnancy/breastfeeding Having Parkinson's disease History of head and neck radiotherapy Users of any kind of medicine except type 2 diabetes and blood pressure medicines People with a history of surgery in the mouth and face that may have affected the salivary glands The presence of any metabolic conditions other than type 2 diabetes and kidney disease suffering from asthma Suffering from glaucoma Infected with hepatitis B and C, HIV
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The volume of unstimulated saliva of people in milliliters. Timepoint: Determination of saliva level in the first day before starting to use and the fourteenth day after starting to use each mouthwash. Method of measurement: Fox questionnaire/Spitting test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Primary outcome: the degree of change in the severity of dry mouth, which is measured using spitting test and Fox questionnaire before and after the intervention. Secondary outcomes: 1. The amount of unstimulated salivary flow (UWS), measured by the standard method in milliliters per minute. 2. Stimulated salivary flow rate (SWS), measured by the standard method in milliliters per minute. Timepoint: The first day and the fourteenth day. Method of measurement: spitting test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University